Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...
2d
Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, ...
Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer ...
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...
In a call with investors, CEO Gail Boudreaux didn’t directly address the killing of UnitedHealthcare’s top executive but spent more time than usual arguing Elevance is working to improve healthcare.
2d
Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...
The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue ...
For the full year, that translated into $175.2 billion in revenue for Elevance (a 2.9% increase over 2023), while profit hit $5.98 billion, almost identical to its total a year ago. Operating revenue ...
Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health fourth-quarter earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded ...
Please go ahead. Good morning, and welcome to Elevance Health's fourth quarter 2024 earnings call. My name is Nathan Rich, Vice President of Investor Relations. With us this morning on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback